Medically reviewed by a licensed healthcare professional. Last updated March 2026.

Key Takeaways

  • Retail pharmacy list prices for GLP-1 injectables range from $935 to $1,650 per month without insurance.
  • Manufacturer direct programs offer significant savings: LillyDirect Zepbound vials at $299-$449/month, NovoCare Wegovy at $499/month [1][2].
  • Oral Wegovy (tablet form, approved December 2025) is available at $149-$299/month at select pharmacies.
  • Compounded semaglutide costs $150-$500/month but is not FDA-approved and carries different risk considerations.
  • Patient assistance programs from Novo Nordisk and Eli Lilly provide free medication to qualifying low-income patients.

Understanding GLP-1 Pricing

GLP-1 medication pricing is unusually opaque. The "list price" set by the manufacturer bears little relationship to what most patients actually pay. Between manufacturer programs, pharmacy discounts, and compounding options, the real cost landscape has multiple tiers.

For patients without insurance coverage — either uninsured or with plans that exclude GLP-1 medications for weight loss — this guide breaks down every available option.

Retail List Prices (Without Any Discount)

These are the prices you would pay at a retail pharmacy without insurance or discount programs:

Medication Monthly List Price Dosing
Wegovy (semaglutide injection) $1,349-$1,650 Weekly injection, 2.4 mg maintenance
Zepbound (tirzepatide injection) $1,059-$1,177 Weekly injection, up to 15 mg
Ozempic (semaglutide injection) $935-$1,029 Weekly injection, up to 2.0 mg
Mounjaro (tirzepatide injection) $1,023-$1,177 Weekly injection, up to 15 mg
Saxenda (liraglutide injection) $1,349-$1,430 Daily injection

These prices are effectively irrelevant for most self-pay patients because substantially lower options exist through manufacturer programs.

Manufacturer Cash-Pay Programs

Both major GLP-1 manufacturers have introduced direct-to-consumer programs that bypass traditional pharmacy pricing.

Eli Lilly: LillyDirect

Eli Lilly launched LillyDirect, a direct-to-consumer pharmacy service that sells Zepbound single-dose vials at significantly reduced prices [1]:

  • 2.5 mg vials: $299/month (starting dose)
  • 5 mg vials: $349/month
  • 10 mg vials: $399/month
  • 15 mg vials: $449/month (maintenance dose)

These are single-dose vials, not the standard auto-injector pens. Patients must draw the medication with a syringe, which requires slightly more technique but results in substantial savings. LillyDirect includes home delivery.

Novo Nordisk: NovoCare

Novo Nordisk offers cash-pay pricing through its NovoCare patient services program [2]:

  • Wegovy injection: $499/month for eligible self-pay patients
  • Oral Wegovy tablet: $149-$299/month at participating pharmacies

The oral Wegovy tablet, approved by the FDA in December 2025, represents the most affordable branded GLP-1 option currently available. It eliminates the need for injections entirely.

Patient Assistance Programs (Free Medication)

Both manufacturers offer free medication to qualifying patients:

  • Novo Nordisk Patient Assistance Program (PAP): Provides Wegovy at no cost to uninsured patients with household income at or below 400% of the Federal Poverty Level [2].
  • Lilly Cares: Provides Zepbound at no cost to uninsured patients who meet income eligibility requirements [1].

Application requires documentation of income, insurance status, and a prescription from a licensed provider. Approval typically takes 2-4 weeks.

Compounded GLP-1 Medications

Compounded versions of semaglutide and tirzepatide are available from compounding pharmacies at lower prices than branded products. These are not FDA-approved and are manufactured under different regulatory oversight [3].

Compounded Semaglutide

  • Typical cost: $150-$500/month depending on dose, pharmacy, and whether prescribed through a telehealth platform or independent provider
  • Availability: Widely available from both 503A (state-regulated) and 503B (FDA-registered) compounding pharmacies

Compounded Tirzepatide

  • Typical cost: $300-$600/month
  • Availability: More limited; the FDA's position on tirzepatide compounding has been subject to legal challenges [3]

Important Considerations for Compounded Medications

Compounded GLP-1 medications are not interchangeable with branded products. Key differences include:

  • No FDA approval: Compounded drugs have not undergone the same efficacy and safety review as branded medications
  • Variable quality: Manufacturing standards depend on the specific compounding pharmacy
  • Regulatory uncertainty: The FDA's enforcement position on GLP-1 compounding has changed multiple times; availability may shift [3]

If you choose compounded medications, verify that the pharmacy is a 503B-registered outsourcing facility operating under FDA inspection. You can search the FDA's outsourcing facility database to confirm registration.

Total Monthly Cost Scenarios

Here is what a self-pay patient can expect to pay in total, including provider visits:

Scenario 1: Lowest Cost (Branded)

  • Oral Wegovy tablet: $149-$299/month
  • Telehealth provider visit: $50-$100/month
  • Total: $199-$399/month

Scenario 2: LillyDirect Zepbound

  • Zepbound vials: $299-$449/month
  • Telehealth or in-person visit: $50-$150/month
  • Total: $349-$599/month

Scenario 3: NovoCare Wegovy Injection

  • Wegovy injection: $499/month
  • Provider visit: $50-$150/month
  • Total: $549-$649/month

Scenario 4: Compounded Semaglutide

  • Compounded semaglutide: $150-$350/month
  • Telehealth visit (often bundled): $0-$100/month
  • Total: $150-$450/month

Additional Strategies to Reduce Costs

Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA)

Prescription GLP-1 medications are eligible HSA and FSA expenses when prescribed by a licensed provider. This effectively provides a tax discount of 20-35% depending on your tax bracket [4].

Pharmacy Discount Cards

GoodRx, RxSaver, and similar platforms offer discount pricing at retail pharmacies. Savings vary but can reduce the cost of branded GLP-1 medications by 10-30% compared to retail pricing.

Appeal Insurance Denials

If your insurance denied coverage, consider appealing. Prior authorization denials are frequently overturned with a letter of medical necessity from your provider. Many clinics will assist with the appeal process at no additional charge.

Compare Provider Pricing

GLP-1 pricing varies significantly between providers, even in the same city. Use our GLP-1 clinic directory to compare pricing, or check our cost guide for detailed pricing by region.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Individual results vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you are experiencing a medical emergency, call 911.

Sources

  1. Eli Lilly. LillyDirect Pharmacy Services. https://www.lillydirect.com/
  2. Novo Nordisk. NovoCare Patient Savings and Assistance Programs. https://www.novocare.com/wegovy/savings-card.html
  3. FDA. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  4. IRS. Publication 502: Medical and Dental Expenses. https://www.irs.gov/publications/p502
  5. KFF Health Tracking Poll, May 2024. "Public Opinion on GLP-1 Drugs for Weight Loss." https://www.kff.org/health-costs/poll-finding/kff-health-tracking-poll-may-2024/
  6. NIH National Institute of Diabetes and Digestive and Kidney Diseases. "Prescription Medications to Treat Overweight & Obesity." https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity